Johnm Oldham News Today

From the prospect of semaglutide and MDMA for substance use disorder to evolving research around personality disorders and OCD, here are 5 key topics from the annual psychiatric meeting.

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions. However, many challenges remain in defining their clinical benefits and overcoming the complex regulatory obstacles to their use. The September issue of Journal of Psychiatric Practice presents a research review and update on therapeutic use of psychedelics – focusing on the use of psilocybin for treatment of depression. The journal is published in the Lippincott portfolio in ...

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions. However, many challenges remain in defining their clinical benefits and overcoming the complex regulatory obstacles to their use. The September issue of Journal of Psychiatric Practice presents a research review and update on therapeutic use of psychedelics – focusing on the use of psilocybin for treatment of depression. The journal is published in the Lippincott portfolio in ...

Combining a form of individual and group therapy that focuses on experiential approaches is effective in reducing borderline personality disorder symptoms, new research suggests.

Early interventions that focus on clinical case management and psychiatric care are effective in young individuals with borderline personality disorder, new research suggests.

Questions about the accuracy of the conditions name, concerns about medical training, and new findings regarding key risk factors and treatment resulted in this weeks top trending clinical topic.

Breaking the Links in the Chain of Violence: Journal of Psychiatric Practice Continues Series on Therapeutic Risk Management Approach Applying chain analysis to identify pathways of reinforcement that can cause violent ideas and behaviors to persist. . An innovative model for therapeutic risk management of the potentially violent patient has been developed by Hal Wortzel, MD, and colleagues of the Rocky Mountain Mental Illness Research, Education and Clinical Center (MIRECC) at the VA Rocky Mo...